11/15
11:13 am
cmmb
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $11.00 price target on the stock, down previously from $13.00.
Low
Report
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $11.00 price target on the stock, down previously from $13.00.
11/15
10:53 am
cmmb
Rating for CMMB
Medium
Report
Rating for CMMB
11/15
10:53 am
cmmb
Rating for CMMB
Medium
Report
Rating for CMMB